个人中心 - 老虎社区

虎皮猫

IP属地：浙江

帖子 · 5帖子 · 5
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 虎皮猫虎皮猫
  ·05-30
  $Summit Therapeutics PLC(SMMT)$
  329 评论
  1
  分享
  举报
- 虎皮猫虎皮猫
  ·2020-09-10
  听听就好了
  非常抱歉，此主贴已删除
  2,899 评论
  1
  分享
  举报
- 虎皮猫虎皮猫
  ·2020-09-04
  快
  非常抱歉，此主贴已删除
  3,466 1
  1
  分享
  举报
- 虎皮猫虎皮猫
  ·2020-08-15
  $TFF Pharmaceuticals(TFFP)$Tffp新药技术。Niclosamide是一种口服驱虫药，于1982年被美国FDA首次批准用于人类，并被列入世界卫生组织的基本药物清单。它已被用于安全地治疗数百万患者。最近，通过重新定位药物用途的筛选，Niclosamide已被确认为一种多功能药物，有潜力重新用于治疗多种病毒感染，例如严重急性呼吸综合征冠状病毒（SARS-CoV），中东呼吸综合征冠状病毒（MERS- CoV），寨卡病毒（ZIKV）等产品，因为其价格便宜且在临床上作为一种FDA批准的药物具有较低的体内毒性。氯硝柳胺已显示出对SARS-CoV-2和完全消除了1.56μM浓度下的病毒抗原合成。但是，烟酰胺具有有限的水溶性，低吸收和口服生物利用度，对其作为潜在抗病毒疗法的发展提出了挑战。TFF Pharmaceuticals的TFF技术已证明可以改善口服形式的氯硝柳胺的溶解度以及干粉形式的药物以直接递送至肺部。
  5,250 2
  1
  分享
  举报
- 虎皮猫虎皮猫
  ·2020-08-14
  $英特尔(INTC)$感觉英特尔和台积电还有一拼吧，最新的消息英特尔架构日，英特尔公布了全新的10纳米SuperFET技术和“分解”设计封装技术！以IDM模式运营的英特尔不一定需要和以代工模式运营的台积电去比拼工艺，因为台积电不是英特尔的真实对手，只要透过六大技术支柱的巧妙组合，去迎战真实对手即可。打败对手就赢得天下！在英特尔和台积电分别推出3D封装技术Foveros和SOIC后，以“打酱油”著称的三星电子日前也紧急披露3D封装X-Cube，全球3D封装大战一触即发。感觉英特尔后面还有机会
  6,674 3
  2
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"77318222255148","uuid":"77318222255148","gmtCreate":1455429309257,"gmtModify":1460385371745,"name":"虎皮猫","pinyin":"hpmhupimao","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/b9c3b91bc0b93aeb280241bc2e9f54a0","hat":"https://static.tigerbbs.com/e6295840391b9cdc17115677ba51429c","hatId":"tiger_head_frame","hatName":"小虎头像框","vip":1,"status":2,"fanSize":1,"headSize":17,"tweetSize":5,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":15,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.48%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.83%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"浙江","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":12,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":440600272359544,"gmtCreate":1748606731230,"gmtModify":1748606732135,"author":{"id":"77318222255148","authorId":"77318222255148","name":"虎皮猫","avatar":"https://static.tigerbbs.com/b9c3b91bc0b93aeb280241bc2e9f54a0","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"77318222255148","idStr":"77318222255148"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SMMT\">$Summit Therapeutics PLC(SMMT)$&nbsp;</a><v-v data-views=\"0\"></v-v>&nbsp;","listText":"<a href=\"https://laohu8.com/S/SMMT\">$Summit Therapeutics PLC(SMMT)$&nbsp;</a><v-v data-views=\"0\"></v-v>&nbsp;","text":"$Summit Therapeutics PLC(SMMT)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/440600272359544","isVote":1,"tweetType":1,"viewCount":329,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":976606803,"gmtCreate":1599674612502,"gmtModify":1703819349712,"author":{"id":"77318222255148","authorId":"77318222255148","name":"虎皮猫","avatar":"https://static.tigerbbs.com/b9c3b91bc0b93aeb280241bc2e9f54a0","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"77318222255148","idStr":"77318222255148"},"themes":[],"htmlText":"听听就好了","listText":"听听就好了","text":"听听就好了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/976606803","repostId":"2066247378","repostType":2,"isVote":1,"tweetType":1,"viewCount":2899,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":978806305,"gmtCreate":1599170643007,"gmtModify":1704221856863,"author":{"id":"77318222255148","authorId":"77318222255148","name":"虎皮猫","avatar":"https://static.tigerbbs.com/b9c3b91bc0b93aeb280241bc2e9f54a0","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"77318222255148","idStr":"77318222255148"},"themes":[],"htmlText":"快","listText":"快","text":"快","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/978806305","repostId":"2064325578","repostType":4,"isVote":1,"tweetType":1,"viewCount":3466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":947771382,"gmtCreate":1597442341246,"gmtModify":1704215893648,"author":{"id":"77318222255148","authorId":"77318222255148","name":"虎皮猫","avatar":"https://static.tigerbbs.com/b9c3b91bc0b93aeb280241bc2e9f54a0","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"77318222255148","idStr":"77318222255148"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TFFP\">$TFF Pharmaceuticals(TFFP)$</a>Tffp新药技术。Niclosamide是一种口服驱虫药，于1982年被美国FDA首次批准用于人类，并被列入世界卫生组织的基本药物清单。它已被用于安全地治疗数百万患者。最近，通过重新定位药物用途的筛选，Niclosamide已被确认为一种多功能药物，有潜力重新用于治疗多种病毒感染，例如严重急性呼吸综合征冠状病毒（SARS-CoV），中东呼吸综合征冠状病毒（MERS- CoV），寨卡病毒（ZIKV）等产品，因为其价格便宜且在临床上作为一种FDA批准的药物具有较低的体内毒性。氯硝柳胺已显示出对SARS-CoV-2和完全消除了1.56μM浓度下的病毒抗原合成。但是，烟酰胺具有有限的水溶性，低吸收和口服生物利用度，对其作为潜在抗病毒疗法的发展提出了挑战。TFF Pharmaceuticals的TFF技术已证明可以改善口服形式的氯硝柳胺的溶解度以及干粉形式的药物以直接递送至肺部。","listText":"<a href=\"https://laohu8.com/S/TFFP\">$TFF Pharmaceuticals(TFFP)$</a>Tffp新药技术。Niclosamide是一种口服驱虫药，于1982年被美国FDA首次批准用于人类，并被列入世界卫生组织的基本药物清单。它已被用于安全地治疗数百万患者。最近，通过重新定位药物用途的筛选，Niclosamide已被确认为一种多功能药物，有潜力重新用于治疗多种病毒感染，例如严重急性呼吸综合征冠状病毒（SARS-CoV），中东呼吸综合征冠状病毒（MERS- CoV），寨卡病毒（ZIKV）等产品，因为其价格便宜且在临床上作为一种FDA批准的药物具有较低的体内毒性。氯硝柳胺已显示出对SARS-CoV-2和完全消除了1.56μM浓度下的病毒抗原合成。但是，烟酰胺具有有限的水溶性，低吸收和口服生物利用度，对其作为潜在抗病毒疗法的发展提出了挑战。TFF Pharmaceuticals的TFF技术已证明可以改善口服形式的氯硝柳胺的溶解度以及干粉形式的药物以直接递送至肺部。","text":"$TFF Pharmaceuticals(TFFP)$Tffp新药技术。Niclosamide是一种口服驱虫药，于1982年被美国FDA首次批准用于人类，并被列入世界卫生组织的基本药物清单。它已被用于安全地治疗数百万患者。最近，通过重新定位药物用途的筛选，Niclosamide已被确认为一种多功能药物，有潜力重新用于治疗多种病毒感染，例如严重急性呼吸综合征冠状病毒（SARS-CoV），中东呼吸综合征冠状病毒（MERS- CoV），寨卡病毒（ZIKV）等产品，因为其价格便宜且在临床上作为一种FDA批准的药物具有较低的体内毒性。氯硝柳胺已显示出对SARS-CoV-2和完全消除了1.56μM浓度下的病毒抗原合成。但是，烟酰胺具有有限的水溶性，低吸收和口服生物利用度，对其作为潜在抗病毒疗法的发展提出了挑战。TFF Pharmaceuticals的TFF技术已证明可以改善口服形式的氯硝柳胺的溶解度以及干粉形式的药物以直接递送至肺部。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/947771382","isVote":1,"tweetType":1,"viewCount":5250,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":947552546,"gmtCreate":1597367666985,"gmtModify":1704215604434,"author":{"id":"77318222255148","authorId":"77318222255148","name":"虎皮猫","avatar":"https://static.tigerbbs.com/b9c3b91bc0b93aeb280241bc2e9f54a0","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"77318222255148","idStr":"77318222255148"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INTC\">$英特尔(INTC)$</a>感觉英特尔和台积电还有一拼吧，最新的消息英特尔架构日，英特尔公布了全新的10纳米SuperFET技术和“分解”设计封装技术！以IDM模式运营的英特尔不一定需要和以代工模式运营的台积电去比拼工艺，因为台积电不是英特尔的真实对手，只要透过六大技术支柱的巧妙组合，去迎战真实对手即可。打败对手就赢得天下！在英特尔和台积电分别推出3D封装技术Foveros和SOIC后，以“打酱油”著称的三星电子日前也紧急披露3D封装X-Cube，全球3D封装大战一触即发。感觉英特尔后面还有机会","listText":"<a href=\"https://laohu8.com/S/INTC\">$英特尔(INTC)$</a>感觉英特尔和台积电还有一拼吧，最新的消息英特尔架构日，英特尔公布了全新的10纳米SuperFET技术和“分解”设计封装技术！以IDM模式运营的英特尔不一定需要和以代工模式运营的台积电去比拼工艺，因为台积电不是英特尔的真实对手，只要透过六大技术支柱的巧妙组合，去迎战真实对手即可。打败对手就赢得天下！在英特尔和台积电分别推出3D封装技术Foveros和SOIC后，以“打酱油”著称的三星电子日前也紧急披露3D封装X-Cube，全球3D封装大战一触即发。感觉英特尔后面还有机会","text":"$英特尔(INTC)$感觉英特尔和台积电还有一拼吧，最新的消息英特尔架构日，英特尔公布了全新的10纳米SuperFET技术和“分解”设计封装技术！以IDM模式运营的英特尔不一定需要和以代工模式运营的台积电去比拼工艺，因为台积电不是英特尔的真实对手，只要透过六大技术支柱的巧妙组合，去迎战真实对手即可。打败对手就赢得天下！在英特尔和台积电分别推出3D封装技术Foveros和SOIC后，以“打酱油”著称的三星电子日前也紧急披露3D封装X-Cube，全球3D封装大战一触即发。感觉英特尔后面还有机会","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":1,"link":"https://laohu8.com/post/947552546","isVote":1,"tweetType":1,"viewCount":6674,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3527667803686145","idStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}